- Home
- DOMO vs VSTM Comparison
DOMO vs VSTM Comparison
Compare DOMO & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- VSTM
- Stock Information
- Founded
- DOMO 2010
- VSTM 2010
- Country
- DOMO United States
- VSTM United States
- Employees
- DOMO N/A
- VSTM N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- DOMO Technology
- VSTM Health Care
- Exchange
- DOMO Nasdaq
- VSTM Nasdaq
- Market Cap
- DOMO 286.1M
- VSTM 239.9M
- IPO Year
- DOMO 2018
- VSTM 2012
- Fundamental
- Price
- DOMO $7.26
- VSTM $5.33
- Analyst Decision
- DOMO Hold
- VSTM Strong Buy
- Analyst Count
- DOMO 5
- VSTM 8
- Target Price
- DOMO $10.10
- VSTM $12.43
- AVG Volume (30 Days)
- DOMO 323.3K
- VSTM 2.4M
- Earning Date
- DOMO 03-06-2025
- VSTM 03-13-2025
- Dividend Yield
- DOMO N/A
- VSTM N/A
- EPS Growth
- DOMO N/A
- VSTM N/A
- EPS
- DOMO N/A
- VSTM N/A
- Revenue
- DOMO $318,458,000.00
- VSTM $10,000,000.00
- Revenue This Year
- DOMO $0.94
- VSTM N/A
- Revenue Next Year
- DOMO N/A
- VSTM $69.02
- P/E Ratio
- DOMO N/A
- VSTM N/A
- Revenue Growth
- DOMO 0.01
- VSTM N/A
- 52 Week Low
- DOMO $6.11
- VSTM $2.10
- 52 Week High
- DOMO $12.23
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- DOMO 48.10
- VSTM 52.51
- Support Level
- DOMO $6.54
- VSTM $5.08
- Resistance Level
- DOMO $7.38
- VSTM $6.02
- Average True Range (ATR)
- DOMO 0.26
- VSTM 0.68
- MACD
- DOMO 0.06
- VSTM -0.06
- Stochastic Oscillator
- DOMO 77.42
- VSTM 49.21
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.